$CRDF 8-K SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year +1 more Date of Report (Date of earliest event reported): October 22, 2026
22 Oct 2026	8-K: Submission of Matters to a Vote of Security Holders On October 22, 2026, Cardiff Oncology, Inc. (the “Company”) held its Special Meeting of Stockholders (the “Special Meeting”). A total of 48,084,246 shares of common stock, constituting a quorum, were represented in person or by valid pro...
14 Sep 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
11 Aug 2026	8-K: Results of Operations and Financial Condition
16 Jul 2026	8-K: Entry into a Material Definitive Agreement; Other Events
11 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2026	8-K: Regulation FD Disclosure
29 May 2026	8-K: Entry into a Material Definitive Agreement
19 May 2026	8-K: Other Events
14 May 2026	8-K: Results of Operations and Financial Condition
09 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
02 Apr 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
25 Feb 2026	8-K: Regulation FD Disclosure
24 Feb 2026	8-K: Completion of Acquisition or Disposition of Assets
27 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition
29 Jul 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
26 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
17 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
08 May 2025	8-K: Results of Operations and Financial Condition

Comments